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INTRODUCTION 
Preterm labor and preterm delivery are critical factors
regarding neonatal morbidity and mortality (1, 2) Much
efforts have been made on prediction, prevention, diagnosis
and treatment of preterm labor, and several previous studies
including the one reported by our university hospital (3)
have shown that there is no great difference regarding neona-
tal morbidity and mortality between the group with preterm
labor after 34 weeks of gestation and the full-term labor
group when proper ante partum management (antibiotics,
steroids treatment) was provided (4-15). Also, it has been
demonstrated that the rates of neonatal mortality and com-
plications are significant in preterm babies born prior to 32
weeks of gestation and with body weight less than 1,500 g
(16, 17). However, relevant studies have expressed diverse
opinions about the risks and safety of preterm infants born
at 32+0-33+6 weeks of gestation (18-20). According to recent
studies, the upper limit of the usage of the uterine contrac-
tion inhibitor for pregnant women with preterm labor has
not been clearly decided (21); yet, some studies even argue
that there is no significant difference in perinatal morbidity
and mortality between pregnant women who stopped tak-
ing uterine contraction inhibitor after 32 weeks of gestation
and those who continued taking it (22). Therefore, this study
aimed to examine the perinatal outcomes of different groups
on the neonates’ conditions at delivery and the neonates’ mor-
bidity and mortality in order to see if preterm labor at 32+0-
33+6 weeks is more dangerous than at other periods; and when
they are safe, if uterine contraction inhibitor can be used as
early as at 32+0 weeks. 
This study identifies safe gestational age of neonates when
mothers go through preterm labor in order to provide an
index to determine whether or not to maintain pregnancy
when there is a risk of preterm delivery due to preterm labor
or premature rupture of membranes (PROM). 
A pregnant woman with preterm labor experiences phys-
ical pain daily. Therefore, it would be a considerable help
for pregnant women as well as doctors if it is possible to
bring gestational age with no post-delivery complications
significantly different full-term delivery sooner. 
MATERIALS AND METHODS
Our research subjects consisted of neonates born at 32+0-
33+6 weeks (184 babies), 34+0-36+6 weeks (472 babies), and
later than 37+0 weeks (2,353 babies) at Inje University Ilsan
Paik hospital from December 1999 to April 2006. The data
were analyzed on the following categories: the conditions of
the mother and the fetus prior to delivery, the condition of
the neonate at birth, and neonatal morbidity and mortality.
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Evaluation of Preterm Delivery between 32
+0-33
+6 Weeks of Gestation 
Preterm labor after 34 weeks of gestation has shown no great difference from full-
term labor in terms of neonatal morbidity and mortality when proper antepartum
management (antibiotics or steroids treatment) is done. However, various studies
have discussed different views on the risks and safety of preterm delivery at 32
+0-
33
+6 weeks of gestation. We evaluated the complications of different preterm groups
that included the neonates born at 32
+0-33
+6 weeks of gestation (142), stratified
randomly selected neonates born at 34
+0-36
+6 weeks of gestation (267) and neonates
born after 37
+0 weeks of gestation (356) at our hospital between December 1999
and April 2006. As a result, it was found that neonates born at 34
+0-36
+6 weeks of
gestation showed no great difference from infants born at full term. However, neonates
born at 32
+0-33
+6 weeks were more likely to be admitted to neonatal intensive care
unit or develop neonatal complications significantly than the neonates born at 34
+0-
36
+6 weeks and at full term. Therefore, it is suggested that neonates born at 32
+0-33
+6
weeks have higher risk of neonatal complications following their preterm labor than
those born at later than 34
+0 weeks. Thus, it would be difficult to accept the idea
that preterm labor at 32
+0-33
+6 weeks is safe.
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We excluded the cases of twins, fetal death in utero, and
improper records (inaccurate gestational week or incorrect
records of the mother and the neonates). Consequently, 142,
267, and 356 cases were examined for the 32+0-33+6 week
group, the 34+0-36+6 weeks group and the more than 37+0
weeks group, respectively, and the last two groups were
selected by using stratified random sampling. 
For mothers, age, obstetrics history (term or preterm deliv-
ery), experience of preterm labor, chorioamnionitis, PROM,
hypertensive disorders of pregnancy, placenta previa, gesta-
tional diabetes mellitus (GDM), and anemia were consid-
ered, and fetal distress, prolapse of the umbilical cord, breech
presentation, hydramnios, and oligohydramnios were includ-
ed in antepartum evaluation of the fetal condition to find
out the correlation with the preterm delivery. Evaluation of
antepartum management included the proper use of antibi-
otics and steroids treatment (when a mother had 2 or more
maternal complications, ‘‘2 or more complications’’ was record-
ed). A neonate’s body weight, sex, Apgar score (1’ and 5’),
and the presence of meconium staining were examined right
after birth. Also, the categories including admission history
of neonatal intensive care unit (NICU) and the period of stay
in NICU, neonatal convulsion, intraventricular hemorrhage
(IVH), neonatal retinopathy, sepsis, respiratory distress syn-
drome (RDS), ventilator care and the rates of fetal death were
used as indicators for neonatal morbidity and mortality. 
Statistical analyses of the data were conducted by using
chi-square examination, Fisher’s exact test, analysis of vari-
ance (ANOVA), and multiple logistic regression analysis,
using the SAS program. We recognized the values with a p
value less than 0.05 as significant.
RESULTS
The results on the condition and treatment of pregnant
women before delivery in the three groups -32+0-33+6 weeks,
34+0-36+6 weeks, and later than 37+0 weeks of gestation-
(Table 1) found no significant difference by maternal age
and history of pregnancy that could be considered to affect
preterm delivery. PROM frequencies were significantly high
in the 32+0-33+6 weeks group and the 34+0-36+6 weeks group
(57.7% and 49.1%), which might be related to the increased
use of the antibiotics as a preventive treatment in these groups
(73.2% and 52.1%). The rate of uterine contraction inhibitor
use to prevent preterm labor was significantly high in the
32+0-33+6 weeks group. Also, the rate of steroid use for RDS
was high up to 28.9%; and as expected, the high rate of
tocolysis and steroid use was found in the groups before 34
weeks. However, using steroid after 34 weeks included moth-
ers treated with steroid before 34 weeks and delivered babies
after 34 weeks. 
When maternal complications were compared (Table 2),
it was found that of maternal complications in the 32+0-33+6
weeks group, the occurrence rates of preeclampsia, placenta
previa, placenta abruptio, and GDM were significantly high.
Eight factors that were found to be significant in Table 1, 2
were considered as confounding variables in analysis of neonatal
Gestational weeks
32≤N<34
(n=142)
34≤N<37
(n=267)
N≥37
(n=356)
Maternal age (yr) 30.25 31.58 31.49
(±4.385) (±4.995) (±4.404)
Parity 0.75 0.68 0.62
(±0.696) (±0.799) (±0.746)
No. of Previous full- 0.70 0.59 0.59
term birth (±0.674) (±0.727) (±0.696)
No. of Previous preterm  0.08 0.11 0.05
birth (±0.279) (±0.436) (±0.281)
Delivery mode
Vaginal delivery  73 112 149
(21.9%) (33.5%) (44.6%)
Cesarean section 69 151 199
(16.5%) (36.0%) (47.5%)
Vaccum 0 4 8
(0%) (33.3%) (66.7%)
Tocolytic therapy* 47 76 6
(33.1%) (28.5%) (1.7%)
Antibiotics* 104 139 40
(73.2%) (52.1%) (11.2%)
Steroid therapy* 41 32 1
(28.9%) (12.0%) (0.3%)
PROM* 82 131 40
(57.7%) (49.1%) (11.2%)
Table 1. Antenatal profile
Values are mean±standard deviation. *p<0.05.
PROM, premature rupture of membranes.
Gestational weeks
32≤N<34
(n=142) 
34≤N<37
(n=267) 
N≥37
(n=356) 
Table 2. Maternal complications
*p<0.05.
PIH, pregnancy-induced hypertension; DM, diabetes mellitus; FGR,
fetal growth restriction.
Chorioamnionitis  7 (4.9%) 3 (1.1%) 1 (0.3%)
PIH*
Mild 18 (18.0%) 46 (46.0%) 36 (36.0%)
Severe 1 (4.2%) 17 (70.8%) 6 (25.0%)
Cord prolapse 0 (0%) 1 (0.4%) 0 (0%)
Placenta previa* 4 (2.8%) 34 (12.7%) 33 (9.3%)
Placenta abruptio* 9 (6.3%) 13 (4.9%) 2 (0.6%)
Fetal distress 12 (8.5%) 23 (8.6%) 22 (6.2%)
FGR 7 (4.9%) 27 (10.1%) 22 (6.2%)
Polyhydramnios 4 (2.8%) 10 (3.7%) 18 (5.1%)
Oligohydramnios 5 (3.5%) 11 (4.1%) 12 (3.4%)
Gestational DM* 4 (2.8%) 16 (6.0%) 74 (20.8%)
Breech presentation 20 (14.1%) 26 (9.7%) 50 (14.0%)
Anemia 69 (48.6%) 132 (49.4%) 180 (50.6%)966 S.S. Lee, H.S. Kwon, and H.M. Choi
morbidity. 
When the neonatal conditions at birth were compared by
gestational weeks (Table 3), the Apgar score less than 7 points
at 1 min was significant among the neonates born at 32+0-33+6
weeks of gestation (41.5%), and large for gestational age
(LGA) baby weight and meconium staining were also found
to be significant. 
Table 4 shows the results of comparing the neonatal diseases
that affect neonatal morbidity. The neonates born after 32+0-
33+6 weeks of gestation had significantly high probability of
hospitalization to NICU (97.9%) and the average period of
stay was longer by 19.11 days. Neonatal complications, includ-
ing ventilator care, RDS, use of antibiotics, sepsis, seizure,
IVH, neonatal death, and congenital anomaly were significant. 
Preeclampsia, placenta previa, placenta abruptio, GDM,
use of antibiotics, steroid, tocolysis, and PROM were also
found to be significantly high in the 32+0-33+6 weeks group.
We conducted multiple logistic regression analysis to exclude
the effect of confounding factors on the occurrence of neona-
tal morbidity; and, the result showed that administration of
NICU, ventilator care, using of antibiotics, and neonatal
complications like RDS seizure, and IVH were statistically
significant (Table 5). 
Because the 32+0-33+6 weeks group had significantly high
occurrence of neonatal complications, we conducted further
analysis regarding the effect of steroid on neonatal compli-
cations (Table 6). However, this study’s statistical findings
did not support the idea that steroid treatment for the neonates
born at 32+0-33+6 weeks of gestation has a significant effect
on the occurrence of neonatal complications.
Gestational weeks
32≤N<34
(n=142) 
34≤N<37
(n=267) 
N≥37
(n=356) 
Table 3. Neonatal conditions at birth 
*p<0.05.
SGA, small for gestational age; LGA, large for gestational age.
Gestational weeks
32≤N<34
(n=142)
34≤N<37
(n=267)
N≥37
(n=356)
NICU admission* 139 (97.9%) 225 (84.3%) 496 (64.8%)
Date of NICU* 19.11 12.24 7.56
(±13.243) (±10.955) (±4.760)
Ventilator care* 31 (21.8%) 13 (4.9%) 9 (2.5%)
RDS* 30 (21.1%) 16 (6.0%) 2 (0.6%)
Antibiotics* 97 (68.3%) 108 (40.4%) 53 (14.9%)
Sepsis* 37 (26.1%) 50 (18.7%) 30 (8.4%)
Seizure* 3 (2.1%) 0 0
IVH* 15 (10.6%) 13 (4.9%) 3 (0.8%)
Retinopathy of  0 1 (0.4%) 0
prematurity
Congenital anomaly* 25 (17.6%) 30 (11.2%) 36 (10.1%)
Neonatal death* 5 (3.5%) 1 (0.4%) 0
Table 4. Neonatal morbidity
*p<0.05.
NICU, neonatal intensive care unit; RDS, respiratory distress syndrome;
IVH, intraventricular hemorrhage.
p value
Apgar score,1 min <7* 0.0001
NICU admission* 0.0001
Ventilator care* 0.0011
RDS* 0.0001
Antibiotics* 0.0003
Sepsis 0.3454
Seizure* 0.0001
IVH* 0.0059
Retinopathy of prematurity 0.5353
Congenital anomaly 0.4707
Neonatal death 0.1588
Table 5. Multiple logistic regression as possible influence fac-
tors of neonatal morbidity 
Possible influence factors of neonatal morbidity; preeclampsia, placen-
ta previa, placenta abruptio, gestational diabetes mellitus, use of antibi-
otics, steroid, tocolysis, and PROM. *p<0.05.
NICU, neonatal intensive care unit; RDS, respiratory distress syndrome;
IVH, intraventricular hemorrhage.
32≤N<34 (n=142)
Steroid apply
+ (N=41) 
Steroid apply
- (N=101)
Table 6. Neonatal morbidity according to steroid therapy
p>0.05.
NICU, neonatal intensive care unite; RDS, respiratory distress syndrome.
Sex
Male 86 (60.6%) 127 (47.6%) 178 (50.0%)
Female 56 (39.4%) 140 (52.4%) 178 (50.0%)
Weight (g)*
SGA 17 (14.7%) 31 (26.7%) 68 (58.6%)
LGA 7 (8.2%) 26 (30.6%) 52 (61.2%)
Apgar score
1 min <7*  59 (41.5%) 80 (30.0%) 36 (10.1%)
5 min <7  12 (8.5%) 12 (4.5%) 5 (1.4%)
Meconium staining*
Mild 2 (1.4%) 4 (1.5%) 27 (7.6%)
Moderate 0 (0%) 3 (1.1%) 11 (3.1%)
Severe 1 (0.7%) 4 (1.5%) 36 (10.1%)
Date of NICU  39 (95.1%) 100 (99.0%)
Ventilator care 10 (24.4%) 21 (20.8%)
RDS 10 (24.4%) 20 (19.8%)
Antibiotics  27 (65.9%) 70 (69.3%)
Sepsis  15 (36.6%) 22 (21.8%)
Seizure 1 (2.4%) 2 (2.0%)
Intraventricular hemorrhage  6 (14.6%) 9 (8.9%)
Retinopathy of prematurity 0 0
Congenital anomaly 10 (24.4%) 15 (14.9%)
Neonatal death  2 (4.9%) 3 (3.0%)Evaluation of Preterm Delivery between 32
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DISCUSSION
Preterm delivery is one of the most important factors of
neonatal mortality and morbidity not only in South Korea
(22) but also in the United States (23). It has been reported
that excluding congenital anomaly, 85% of neonatal mor-
tality is caused by preterm delivery, and in many countries,
a tremendous amount of cost is demanded to treat perinatal
diseases. 
Until now, the expenditure allotted for the treatment of
preterm infants was not efficiently used because the factors
that affect perinatal morbidity and mortality and delivery
time of preterm labor have not been clearly identified. 
Recently, the incidence of perinatal death has been con-
siderably decreased as the neonatology has been making its
advance, but it is still a critical issue to manage morbidity
and mortality after preterm delivery. Gestational age can be
one of the most important predictors of morbidity and mor-
tality of neonates. It is clear that the rates of infant survival
and of being born as normal infants are high as gestational
age approaches close to the full term. 
In this study, the incidence of PROM, preeclampsia, pla-
centa previa, placenta abruptio and GDM were significantly
high in the 32+0-33+6 weeks group, which once again demon-
strated that PROM is one of the most important decision
factors of preterm delivery. 
The high incidence of using tocolysis, antibiotics, steroids
at 32 gestational weeks is thus inevitable. And maternal
complications were analyzed as shown in Table 1, 2 to con-
duct accurate statistical processing with significant maternal
complications considered as confounding variables. 
According to Helen et al. (21), the rate of admission to
NICU was high for the preterm infant born at 32+0-33+6
weeks of gestation, but our study found that 97.9% of the
preterm infant born at 32+0-33+6 weeks and 84.3% of the
preterm infant born at 34+0-36+6 weeks were admitted to
NICU. These figures can be attributed to the fact that the
admission rate of preterm infants to NICU is somewhat high-
er in Korea as preterm infants, even those with no severe
problems, are tended to be observed in NICU for some period
of time. However, even excluding these cases, the rate of
admission to NICU is still high.
One minute Apgar score included in neonatal conditions
at birth was significantly low in a previous study by Inje
University Ilsan Paik hospital (15). In this study with a high-
er number of samples, only one minute Apgar score was sig-
nificantly low. This reaffirms that in the case of preterm
infants born at 32+0-33+6 weeks, the rate of the necessity of
immediate cardiopulmonary resuscitation is significantly
higher than the 34+0-36+6 weeks group. 
In terms of prenatal complications, the neonates born before
32+0-33+6 weeks of gestation was overall weak, excluding
the cases of sepsis, neonatal death, retinopathy of prematuri-
ty, and congenital anomaly. Jones et al. (24) reported that
the incidence of admission to NICU and the rate of RDS
occurrence markedly decreased as the gestational age advances
after 34 weeks. However, the rate of neonatal morbidity did
not significantly decline after 34 weeks of gestation. Our
study confirmed that the incidence of admission to NICU
and the rate of RDS occurrence had little difference between
the 32+0-33+6 weeks group and the 34+0-36+6 weeks group. 
According to Grgic et al. (25) and Crowther et al. (26),
the complications related to neonatal respiratory system have
noticeably decreased when steroids were used to the neonates
born prior to 32+0-33+6 weeks. In order to examine the rate
of complications in the respiratory system, the 32+0-33+6
weeks group was divided into the group with steroidal treat-
ment and the group without it were compared, but it was
not found that steroid treatment had significantly reduced
neonatal complications. Despite the extensive samples, the
results showed no significant efficiency of steroid on respira-
tory maturity. This might be explained that only the use of
ventilator care and the presence of RDS were used to evalu-
ate the efficiency of steroidal treatment; we expect to have
more precise results if the period of time using ventilator
care and the grade of RDS were included. Our university is
planning to conduct further research with more samples and
more detailed analysis of the preterm labor at 32+0-33+6 weeks
and 34+0-36+6 weeks of gestation. 
Although it is known that the survival rates of full-term
infants and preterm infants after 34 weeks of gestation are
of no difference, there existed a debate regarding ante par-
tum management of preterm infants born at 32+0-33+6 weeks.
Throughout this study we expected earlier preterm delivery
by several days from 34+0 weeks having appropriate antepar-
tum management. However, the neonatal complications
compared between preterm infants born at 32+0-33+6 weeks
and at full term showed very significant differences from
which we concluded that active management is necessary in
order to keep up gestational age as close to full term as pos-
sible. 
This study aimed at clarifying the claim that there was no
significant difference in preterm labor between 32+0-33+6
weeks and 34+0-36+6 weeks based on the data generated from
the patients of our hospital. However, neonatal complications
of the preterm labor at 32+0-33+6 weeks are significantly high
that it is difficult to fully accept the notion that preterm
labor at 32+0-33+6 weeks is safe.
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